K. Berecek

Biochemistry and cell biology of angiotensin-converting enzyme and converting enzyme inhibitors.

L. Zhang, K. Berecek, 1995, Advances in experimental medicine and biology.

Prevention of genetic hypertension by early treatment of spontaneously hypertensive rats with the angiotensin converting enzyme inhibitor captopril.

J. N. Wu, K. Berecek, 1993, Hypertension.

Pressor and bradycardic effects of centrally administered relaxin in conscious rats.

H. Jin, R. Yang, S. Bunting, 1995, American journal of hypertension.

Effects of early captopril treatment and its removal on plasma angiotensin converting enzyme (ACE) activity and arginine vasopressin in hypertensive rats (SHR) and normotensive rats (WKY).

L. Zhang, K. Berecek, D. Edwards, 1996, Clinical and experimental hypertension.

early treatment with the angiotensin-converting enzyme inhibitor captopril Changes in renal angiotensin II receptors in spontaneously hypertensive rats by

K. Berecek, Jian-Nan Wu, D. Edwards, 2011 .

Changes in renal angiotensin II receptors in spontaneously hypertensive rats by early treatment with the angiotensin-converting enzyme inhibitor captopril.

J. N. Wu, K. Berecek, K. Berecek, 1994, Hypertension.

VASOPRESSIN PROJECTIONS AND CENTRAL CONTROL OF CARDIOVASCULAR FUNCTION *

M. Brody, K. Barron, K. Berecek, 1982, Annals of the New York Academy of Sciences.

Quantification of Angiotensin-Converting Enzyme (ACE) Activity.

Q. Meng, K. Berecek, 2001, Methods in Molecular Medicine.